Quinapril Tablet
Product Images NDC 69097-843

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Quinapril (NDC 69097-843). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Quinapril Hydrochloride 10mg

Label for Quinapril Tablets, USP 10 mg oral tablets, containing 90 tablets per container. The label includes storage instructions, noting temperature control between 20° to 25°C and protection from light. Manufactured by InvaGen Pharmaceuticals and labeled for Cipla USA Inc. The label displays the NDC 69097-841-05, barcode, and a QR code.*

FDA Label Image

Quinapril Hydrochloride 20mg

Label for Quinapril Tablets USP 20 mg from Cipla USA Inc., containing 90 tablets. The label includes dosage strength, storage instructions to keep at controlled room temperature and protect from light, and dispensing recommendations. It shows the NDC 69097-842-05 and manufacturing details by InvaGen Pharmaceuticals, a Cipla subsidiary.*

FDA Label Image

Quinapril Hydrochloride 40mg

Label for Quinapril Tablets, USP 40 mg by Cipla USA Inc. The label indicates a 90 tablet count and includes storage instructions at controlled room temperature with protection from light. Manufacturing information lists InvaGen Pharmaceuticals, a Cipla subsidiary, with addresses in Hauppauge, NY, and Warren, NJ. The label also features a barcode and QR code.*

FDA Label Image

Quinapril Hydrochloride 5mg

Label for Quinapril Tablets, USP 5 mg by Cipla USA Inc. The label shows NDC 69097-839-05, contains 90 tablets, and includes storage instructions to keep at 20° to 25°C (68° to 77°F) with allowed excursions. It advises dispensing in a well-closed container and refers to the package insert for dosage and use information. The label also features a barcode and a QR code for tracking details.*

FDA Label Image

Image (B1bc5d1c Af0b 46a3 B116 C980f3009dfb 01)

Chemical structure of Quinapril hydrochloride, with molecular weight 474.98, showing the detailed molecular formula including functional groups and the hydrochloride component.*

FDA Label Image

Image (B1bc5d1c Af0b 46a3 B116 C980f3009dfb 02)

A data table titled 'Adverse Events in Placebo-Controlled Trials' comparing incidence rates of various adverse events between Quinapril (N=1563) and Placebo (N=579). It lists events like headache, dizziness, fatigue, coughing, nausea/vomiting, and abdominal pain, with percentages and discontinuance rates for both groups.*

FDA Label Image

Image (B1bc5d1c Af0b 46a3 B116 C980f3009dfb 03)

A data table presenting maximum recommended initial dosing of Quinapril based on creatinine clearance levels. It lists dosages of 10 mg, 5 mg, and 2.5 mg associated with specific creatinine clearance ranges and notes insufficient data for clearance below 10 mL/min.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.